Brand
Glenmark Therapeutics, Inc.
1 federal recall on file. We monitor every CPSC, FDA, USDA, and NHTSA notice for Glenmark Therapeutics, Inc. and translate it into plain English — free weekly digest, optional same-day alerts.
- 2023-07-26FDA-DrugClass IIFamotidine Tablets, USP, 20mg, 200-count bottle within a carton, Distributed by: Glenmark Therapeutics Inc., USA, Mahwah, NJ 07430, Made in India, NDC 72657-113-20.
Labeling: Label Error on Declared Strength: some cartons labeled and containing 20 mg may have an external label placed on the side of the carton indicating strength as 10 mg.
Get notified about new Glenmark Therapeutics, Inc. recalls
Free weekly digest. We email when a new federal recall affects Glenmark Therapeutics, Inc. or anything else in your household.
Get the Sunday BriefExplore other recall topics
By hazard
By state